Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
University of Verona · Essen University Hospital · +23 more institutions
Abstract
Myeloid-derived suppressor cells (MDSCs) have emerged as major regulators of immune responses in cancer and other pathological conditions. In recent years, ample evidence supports key contributions of MDSC to tumour progression through both immune-mediated mechanisms and those not directly associated with immune suppression. MDSC are the subject of intensive research with >500 papers published in 2015 alone. However, the phenotypic, morphological and functional heterogeneity of these cells generates confusion in investigation and analysis of their roles in inflammatory responses. The purpose of this communication is to suggest characterization standards in the burgeoning field of MDSC research.
Citation impact
- FWCI
- 104.93
- Percentile
- 100%
- References
- 83
Authors
15Topics & keywords
- Myeloid-derived Suppressor Cell
- Immune system
- Suppressor
- Confusion
- Biology
- Phenotype
- Immunology
- Myeloid
- Good health and well-being
Funding
- SJSt. Jude Children's Research HospitalAward: CA21765
- DKDeutsches KrebsforschungszentrumAward: CA157
- ALAmerican Lebanese Syrian Associated CharitiesAward: CA21765
- DFDeutsche ForschungsgemeinschaftAward: BM1404
- MDMinistero della Salute
- MDMinistero dell’Istruzione, dell’Università e della RicercaAwards: RBAP11H2R9_005, B31J11000420001
- AIAssociazione Italiana per la Ricerca sul CancroAwards: 12886, 12182, 14103, 15585, 14194
- NINational Institutes of HealthAwards: P30 CA21765, CA21765, GM021248, CA 084488